AlzeCure Pharma
1.90 SEK
-1.81 %
Less than 1K followers
ALZCUR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for AlzeCure Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -7.7 | -9.7 | -36.1 | -10.2 | -9.8 | -10.1 | -17.6 | -46.6 |
| EBIT | -7.8 | -9.6 | -36.1 | -10.2 | -9.8 | -10.1 | -17.9 | -47.9 |
| EBIT-% | ||||||||
| Profit before taxes | -7.5 | -9.1 | -35.2 | -10.1 | -9.7 | -10.0 | -17.7 | -47.7 |
| Net income | -7.5 | -9.1 | -35.2 | -10.1 | -9.7 | -10.0 | -17.7 | -47.7 |